Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04744571

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04744571
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04744571. Randomized; no masking; primary purpose treatment. Start 2021-02 (anticipated); primary completion 2022-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions
Condition
Coronary Occlusion
Condition
Chronic Total Occlusion of Coronary Artery
Condition
Drug-Eluting Stents
Intervention (Drug)
aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
Intervention (Device)
coronary wires. or coronary balloons
Intervention (Other)
drug-coated balloon
Intervention (Device)
drug-eluting stent
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct04744571
Content hash
24865be8c789f4a661b61a4a0d62babf50c696f5374a599add11e00ed66ee598